-
Publication Venue For
-
Adaptation of an R5 Simian-Human Immunodeficiency Virus Encoding an HIV Clade A Envelope with or without Ablation of Adaptive Host Immunity: Differential Selection of Viral Mutants..
93.
2019
-
Bridging Vaccine-Induced HIV-1 Neutralizing and Effector Antibody Responses in Rabbit and Rhesus Macaque Animal Models..
93.
2019
-
Rare Detection of Antiviral Functions of Polyclonal IgA Isolated from Plasma and Breast Milk Compartments in Women Chronically Infected with HIV-1..
93.
2019
-
Modulation of sialic acid dependence influences the CNS transduction profile of adeno-associated viruses.
2019
-
Coadministration of CH31 Broadly Neutralizing Antibody Does Not Affect Development of Vaccine-Induced Anti-HIV-1 Envelope Antibody Responses in Infant Rhesus Macaques..
93.
2019
-
Intrahost Dynamics of Human Cytomegalovirus Variants Acquired by Seronegative Glycoprotein B Vaccinees..
93.
2019
-
Closing and Opening Holes in the Glycan Shield of HIV-1 Envelope Glycoprotein SOSIP Trimers Can Redirect the Neutralizing Antibody Response to the Newly Unmasked Epitopes..
93.
2019
-
Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC..
93.
2019
-
Adjuvant-Dependent Enhancement of HIV Env-Specific Antibody Responses in Infant Rhesus Macaques..
92.
2018
-
Antisense-Derived HIV-1 Cryptic Epitopes Are Not Major Drivers of Viral Evolution during the Acute Phase of Infection..
92.
2018
-
Engineered Oncolytic Poliovirus PVSRIPO Subverts MDA5-Dependent Innate Immune Responses in Cancer Cells..
92.
2018
-
Control of Heterologous Simian Immunodeficiency Virus SIVsmE660 Infection by DNA and Protein Coimmunization Regimens Combined with Different Toll-Like-Receptor-4-Based Adjuvants in Macaques..
92.
2018
-
Divergent Human-Origin Influenza Viruses Detected in Australian Swine Populations..
92.
2018
-
Reply to Gantt et al., "Higher Expectations for a Vaccine To Prevent Congenital Cytomegalovirus Infection"..
92.
2018
-
The Influenza B Virus Hemagglutinin Head Domain Is Less Tolerant to Transposon Mutagenesis than That of the Influenza A Virus..
92.
2018
-
Mapping and Engineering Functional Domains of the Assembly-Activating Protein of Adeno-associated Viruses..
92.
2018
-
Novel Strategy To Adapt Simian-Human Immunodeficiency Virus E1 Carrying env from an RV144 Volunteer to Rhesus Macaques: Coreceptor Switch and Final Recovery of a Pathogenic Virus with Exclusive R5 Tropism..
92.
2018
-
Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal Ex Vivo..
92.
2018
-
Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape..
92.
2018
-
Importance of neutralizing monoclonal antibodies targeting multiple antigenic sites on the Middle East respiratory syndrome coronavirus spike glycoprotein to avoid neutralization escape.
92.
2018
-
Intranasal Live Influenza Vaccine Priming Elicits Localized B Cell Responses in Mediastinal Lymph Nodes..
92.
2018
-
Advancing Our Understanding of Protective Maternal Immunity as a Guide for Development of Vaccines To Reduce Congenital Cytomegalovirus Infections..
92.
2018
-
Dengue Virus Selectively Annexes Endoplasmic Reticulum-Associated Translation Machinery as a Strategy for Co-opting Host Cell Protein Synthesis..
92.
2018
-
HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees..
92.
2018
-
HIV-1-Specific IgA Monoclonal Antibodies from an HIV-1 Vaccinee Mediate Galactosylceramide Blocking and Phagocytosis..
92.
2018
-
Immunogenicity in Rabbits of HIV-1 SOSIP Trimers from Clades A, B, and C, Given Individually, Sequentially, or in Combination..
92.
2018
-
Immunogenicity of NYVAC Prime-Protein Boost Human Immunodeficiency Virus Type 1 Envelope Vaccination and Simian-Human Immunodeficiency Virus Challenge of Nonhuman Primates..
92.
2018
-
A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques..
92.
2018
-
Neutralizing Activity of Broadly Neutralizing Anti-HIV-1 Antibodies against Clade B Clinical Isolates Produced in Peripheral Blood Mononuclear Cells..
92.
2018
-
Combination Adenovirus and Protein Vaccines Prevent Infection or Reduce Viral Burden after Heterologous Clade C Simian-Human Immunodeficiency Virus Mucosal Challenge..
92.
2018
-
Polyploidy and Mitotic Cell Death Are Two Distinct HIV-1 Vpr-Driven Outcomes in Renal Tubule Epithelial Cells..
92.
2018
-
c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection..
92.
2018
-
Correction for Hraber et al., "Panels of HIV-1 Subtype C Env Reference Strains for Standardized Neutralization Assessments"..
92.
2018
-
HIV-Exposed Infants Vaccinated with an MF59/Recombinant gp120 Vaccine Have Higher-Magnitude Anti-V1V2 IgG Responses than Adults Immunized with the Same Vaccine..
92.
2018
-
HIV-1 gp120 and Modified Vaccinia Virus Ankara (MVA) gp140 Boost Immunogens Increase Immunogenicity of a DNA/MVA HIV-1 Vaccine..
91.
2017
-
Pathogenic Correlates of Simian Immunodeficiency Virus-Associated B Cell Dysfunction..
91.
2017
-
HIV DNA-Adenovirus Multiclade Envelope Vaccine Induces gp41 Antibody Immunodominance in Rhesus Macaques..
91.
2017
-
Cross-Linking of a CD4-Mimetic Miniprotein with HIV-1 Env gp140 Alters Kinetics and Specificities of Antibody Responses against HIV-1 Env in Macaques..
91.
2017
-
Increased, Durable B-Cell and ADCC Responses Associated with T-Helper Cell Responses to HIV-1 Envelope in Macaques Vaccinated with gp140 Occluded at the CD4 Receptor Binding Site..
91.
2017
-
Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1..
91.
2017
-
Panels of HIV-1 Subtype C Env Reference Strains for Standardized Neutralization Assessments..
91.
2017
-
Reducing V3 Antigenicity and Immunogenicity on Soluble, Native-Like HIV-1 Env SOSIP Trimers..
91.
2017
-
Glycosylation Benchmark Profile for HIV-1 Envelope Glycoprotein Production Based on Eleven Env Trimers..
91.
2017
-
HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Primates..
91.
2017
-
Maternal Binding and Neutralizing IgG Responses Targeting the C-Terminal Region of the V3 Loop Are Predictive of Reduced Peripartum HIV-1 Transmission Risk..
91.
2017
-
Structure-Based Design of a Soluble Prefusion-Closed HIV-1 Env Trimer with Reduced CD4 Affinity and Improved Immunogenicity..
91.
2017
-
Superiority in Rhesus Macaques of Targeting HIV-1 Env gp140 to CD40 versus LOX-1 in Combination with Replication-Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses..
91.
2017
-
Viral Epitranscriptomics..
91.
2017
-
Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediated Cytotoxicity Responses..
91.
2017
-
RPLP1 and RPLP2 Are Essential Flavivirus Host Factors That Promote Early Viral Protein Accumulation..
91.
2017
-
Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies..
91.
2017
-
Deep Sequencing of Influenza A Virus from a Human Challenge Study Reveals a Selective Bottleneck and Only Limited Intrahost Genetic Diversification..
90:11247-11258.
2016
-
Fc Receptor-Mediated Activities of Env-Specific Human Monoclonal Antibodies Generated from Volunteers Receiving the DNA Prime-Protein Boost HIV Vaccine DP6-001..
90:10362-10378.
2016
-
Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice..
90:10209-10219.
2016
-
Characterization of Simian Immunodeficiency Virus Variants Anatomically Compartmentalized in Plasma and Milk in Chronically Infected African Green Monkeys..
90:8795-8808.
2016
-
Induction of Heterologous Tier 2 HIV-1-Neutralizing and Cross-Reactive V1/V2-Specific Antibodies in Rabbits by Prime-Boost Immunization..
90:8644-8660.
2016
-
Virus-Like Particles Displaying Trimeric Simian Immunodeficiency Virus (SIV) Envelope gp160 Enhance the Breadth of DNA/Modified Vaccinia Virus Ankara SIV Vaccine-Induced Antibody Responses in Rhesus Macaques..
90:8842-8854.
2016
-
Optimization of the Solubility of HIV-1-Neutralizing Antibody 10E8 through Somatic Variation and Structure-Based Design..
90:5899-5914.
2016
-
Characterization of the Adeno-Associated Virus 1 and 6 Sialic Acid Binding Site..
90:5219-5230.
2016
-
Superior Efficacy of a Human Immunodeficiency Virus Vaccine Combined with Antiretroviral Prevention in Simian-Human Immunodeficiency Virus-Challenged Nonhuman Primates..
90:5315-5328.
2016
-
Antibodies Elicited by Multiple Envelope Glycoprotein Immunogens in Primates Neutralize Primary Human Immunodeficiency Viruses (HIV-1) Sensitized by CD4-Mimetic Compounds..
90:5031-5046.
2016
-
Combined HIV-1 Envelope Systemic and Mucosal Immunization of Lactating Rhesus Monkeys Induces a Robust Immunoglobulin A Isotype B Cell Response in Breast Milk..
90:4951-4965.
2016
-
Derivation and Characterization of a CD4-Independent, Non-CD4-Tropic Simian Immunodeficiency Virus..
90:4966-4980.
2016
-
Potential To Streamline Heterologous DNA Prime and NYVAC/Protein Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved Antigens..
90:4133-4149.
2016
-
A Highly Conserved Residue of the HIV-1 gp120 Inner Domain Is Important for Antibody-Dependent Cellular Cytotoxicity Responses Mediated by Anti-cluster A Antibodies..
90:2127-2134.
2016
-
Enhanced Immune Responses to HIV-1 Envelope Elicited by a Vaccine Regimen Consisting of Priming with Newcastle Disease Virus Expressing HIV gp160 and Boosting with gp120 and SOSIP gp140 Proteins..
90:1682-1686.
2016
-
New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional Potency..
90:76-91.
2016
-
Replication-Competent Influenza B Reporter Viruses as Tools for Screening Antivirals and Antibodies..
89:12226-12231.
2015
-
Breast Milk of HIV-Positive Mothers Has Potent and Species-Specific In Vivo HIV-Inhibitory Activity..
89:10868-10878.
2015
-
Cooperation between the Hepatitis C Virus p7 and NS5B Proteins Enhances Virion Infectivity..
89:11523-11533.
2015
-
Epstein-Barr Viruses (EBVs) Deficient in EBV-Encoded RNAs Have Higher Levels of Latent Membrane Protein 2 RNA Expression in Lymphoblastoid Cell Lines and Efficiently Establish Persistent Infections in Humanized Mice..
89:11711-11714.
2015
-
Phenotypic Correlates of HIV-1 Macrophage Tropism..
89:11294-11311.
2015
-
Association of HIV-1 Envelope-Specific Breast Milk IgA Responses with Reduced Risk of Postnatal Mother-to-Child Transmission of HIV-1..
89:9952-9961.
2015
-
Elite Control, Gut CD4 T Cell Sparing, and Enhanced Mucosal T Cell Responses in Macaca nemestrina Infected by a Simian Immunodeficiency Virus Lacking a gp41 Trafficking Motif..
89:10156-10175.
2015
-
Soluble Envelope Glycoprotein Trimers from a CD4-Independent HIV-1 Elicit Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies in Guinea Pigs..
89:10707-10711.
2015
-
A Screen for Extracellular Signal-Regulated Kinase-Primed Glycogen Synthase Kinase 3 Substrates Identifies the p53 Inhibitor iASPP..
89:9232-9241.
2015
-
An Enhanced Synthetic Multiclade DNA Prime Induces Improved Cross-Clade-Reactive Functional Antibodies when Combined with an Adjuvanted Protein Boost in Nonhuman Primates..
89:9154-9166.
2015
-
Cocrystal Structures of Antibody N60-i3 and Antibody JR4 in Complex with gp120 Define More Cluster A Epitopes Involved in Effective Antibody-Dependent Effector Function against HIV-1..
89:8840-8854.
2015
-
Epidemiology, Evolution, and Recent Outbreaks of Avian Influenza Virus in China..
89:8671-8676.
2015
-
Rapid Development of gp120-Focused Neutralizing B Cell Responses during Acute Simian Immunodeficiency Virus Infection of African Green Monkeys..
89:9485-9498.
2015
-
Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus Infection..
89:8334-8345.
2015
-
Comparable Antigenicity and Immunogenicity of Oligomeric Forms of a Novel, Acute HIV-1 Subtype C gp145 Envelope for Use in Preclinical and Clinical Vaccine Research..
89:7478-7493.
2015
-
Comparative Analysis of the Glycosylation Profiles of Membrane-Anchored HIV-1 Envelope Glycoprotein Trimers and Soluble gp140..
89:8245-8257.
2015
-
Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman Primates..
89:8525-8539.
2015
-
Inhibitory Effect of Individual or Combinations of Broadly Neutralizing Antibodies and Antiviral Reagents against Cell-Free and Cell-to-Cell HIV-1 Transmission..
89:7813-7828.
2015
-
Two-Year Follow-Up of Macaques Developing Intermittent Control of the Human Immunodeficiency Virus Homolog Simian Immunodeficiency Virus SIVmac251 in the Chronic Phase of Infection..
89:7521-7535.
2015
-
Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman Primates..
89:8643-8650.
2015
-
MAVS Coordination of Antiviral Innate Immunity..
89:6974-6977.
2015
-
Particle-to-PFU Ratio of Ebola Virus Influences Disease Course and Survival in Cynomolgus Macaques.
89:6773-6781.
2015
-
Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost..
89:6462-6480.
2015
-
Sustained Delivery of a Broadly Neutralizing Antibody in Nonhuman Primates Confers Long-Term Protection against Simian/Human Immunodeficiency Virus Infection..
89:5895-5903.
2015
-
CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus (SIV) vaccine enhances protection against neutralization-resistant mucosal SIV infection..
89:4690-4695.
2015
-
DNA vaccine molecular adjuvants SP-D-BAFF and SP-D-APRIL enhance anti-gp120 immune response and increase HIV-1 neutralizing antibody titers..
89:4158-4169.
2015
-
Unique glycan signatures regulate adeno-associated virus tropism in the developing brain..
89:3976-3987.
2015
-
Improving neutralization potency and breadth by combining broadly reactive HIV-1 antibodies targeting major neutralization epitopes..
89:2659-2671.
2015
-
Adaptation of pandemic H2N2 influenza A viruses in humans..
89:2442-2447.
2015
-
Correction to Heavy Chain-Only IgG2b Llama antibody effects Near-Pan HIV-1 neutralization by recognizing a CD4-induced epitope that includes elements of coreceptor- and CD4-binding sites [Journal of Virology 87, 18, (2013) 10173-10181].
89:883-885.
2015
-
Polyreactivity and autoreactivity among HIV-1 antibodies..
89:784-798.
2015
-
Enhanced potency of a broadly neutralizing HIV-1 antibody in vitro improves protection against lentiviral infection in vivo..
88:12669-12682.
2014
-
Impact of clade, geography, and age of the epidemic on HIV-1 neutralization by antibodies..
88:12623-12643.
2014
-
Induction of viral, 7-methyl-guanosine cap-independent translation and oncolysis by mitogen-activated protein kinase-interacting kinase-mediated effects on the serine/arginine-rich protein kinase..
88:13135-13148.
2014
-
Mitogen-activated protein kinase-interacting kinase regulates mTOR/AKT signaling and controls the serine/arginine-rich protein kinase-responsive type 1 internal ribosome entry site-mediated translation and viral oncolysis..
88:13149-13160.
2014
-
Structural definition of an antibody-dependent cellular cytotoxicity response implicated in reduced risk for HIV-1 infection..
88:12895-12906.
2014
-
Viruses and RNA interference: issues and controversies..
88:12934-12936.
2014
-
Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR/Cas RNA-guided endonuclease..
88:11965-11972.
2014
-
CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus SIV239 vaccine enhances SIV-specific humoral and cellular immunity and improves protection against a heterologous SIVE660 mucosal challenge..
88:9579-9589.
2014
-
Envelope glycoprotein binding to the integrin α4β7 is not a general property of most HIV-1 strains..
88:10767-10777.
2014
-
Spatial localization of the Ebola virus glycoprotein mucin-like domain determined by cryo-electron tomography..
88:10958-10962.
2014
-
Transcriptional and posttranscriptional regulation of cytokine gene expression in HIV-1 antigen-specific CD8+ T cells that mediate virus inhibition..
88:9514-9528.
2014
-
Analysis of HLA A*02 association with vaccine efficacy in the RV144 HIV-1 vaccine trial..
88:8242-8255.
2014
-
Vaccine-induced HIV-1 envelope gp120 constant region 1-specific antibodies expose a CD4-inducible epitope and block the interaction of HIV-1 gp140 with galactosylceramide..
88:9406-9417.
2014
-
HIV-1 vaccine-induced C1 and V2 Env-specific antibodies synergize for increased antiviral activities..
88:7715-7726.
2014
-
Replication of many human viruses is refractory to inhibition by endogenous cellular microRNAs..
88:8065-8076.
2014
-
CD4-mimetic small molecules sensitize human immunodeficiency virus to vaccine-elicited antibodies..
88:6542-6555.
2014
-
Capacity for infectious HIV-1 virion capture differs by envelope antibody specificity..
88:5165-5170.
2014
-
Identification of novel, highly expressed retroviral microRNAs in cells infected by bovine foamy virus..
88:4679-4686.
2014
-
Global panel of HIV-1 Env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies..
88:2489-2507.
2014
-
Global panel of HIV-1 env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies.
88:2489-2507.
2014
-
Interaction with cellular CD4 exposes HIV-1 envelope epitopes targeted by antibody-dependent cell-mediated cytotoxicity.
88:2633-2644.
2014
-
Interaction with cellular CD4 exposes HIV-1 envelope epitopes targeted by antibody-dependent cell-mediated cytotoxicity..
88:2633-2644.
2014
-
Toll-like receptor 7/8 (TLR7/8) and TLR9 agonists cooperate to enhance HIV-1 envelope antibody responses in rhesus macaques..
88:3329-3339.
2014
-
A vaccine against CCR5 protects a subset of macaques upon intravaginal challenge with simian immunodeficiency virus SIVmac251..
88:2011-2024.
2014
-
Evolutionary conservation of primate lymphocryptovirus microRNA targets..
88:1617-1635.
2014
-
Evolution and diversity in human herpes simplex virus genomes..
88:1209-1227.
2014
-
Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR/Cas RNA-guided endonuclease.
88:11965-11972.
2014
-
Resistance to infection, early and persistent suppression of simian immunodeficiency virus SIVmac251 viremia, and significant reduction of tissue viral burden after mucosal vaccination in female rhesus macaques..
88:212-224.
2014
-
Multiple roles for sialylated glycans in determining the cardiopulmonary tropism of adeno-associated virus 4..
87:13206-13213.
2013
-
Robust neutralizing antibodies elicited by HIV-1 JRFL envelope glycoprotein trimers in nonhuman primates..
87:13239-13251.
2013
-
Effects of cellular activation on anti-HIV-1 restriction factor expression profile in primary cells..
87:11924-11929.
2013
-
Epstein-Barr virus induces global changes in cellular mRNA isoform usage that are important for the maintenance of latency..
87:12291-12301.
2013
-
Neutralizing IgG at the portal of infection mediates protection against vaginal simian/human immunodeficiency virus challenge..
87:11604-11616.
2013
-
Neutralizing igG at the portal of infection mediates protection against vaginal simian/human immunodeficiency virus challenge.
87:11603-11616.
2013
-
Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses..
87:10435-10446.
2013
-
Lack of B cell dysfunction is associated with functional, gp120-dominant antibody responses in breast milk of simian immunodeficiency virus-infected African green monkeys..
87:11121-11134.
2013
-
Transient compartmentalization of simian immunodeficiency virus variants in the breast milk of african green monkeys..
87:11292-11299.
2013
-
A Novel Rabbit Monoclonal Antibody Platform To Dissect the Diverse Repertoire of Antibody Epitopes for HIV-1 Env Immunogen Design.
87:10232-10243.
2013
-
A novel rabbit monoclonal antibody platform to dissect the diverse repertoire of antibody epitopes for HIV-1 Env immunogen design..
87:10232-10243.
2013
-
Evolutionarily conserved epitopes on human immunodeficiency virus type 1 (HIV-1) and feline immunodeficiency virus reverse transcriptases detected by HIV-1-infected subjects..
87:10004-10015.
2013
-
Heavy chain-only IgG2b llama antibody effects near-pan HIV-1 neutralization by recognizing a CD4-induced epitope that includes elements of coreceptor- and CD4-binding sites..
87:10173-10181.
2013
-
Immune focusing and enhanced neutralization induced by HIV-1 gp140 chemical cross-linking..
87:10163-10172.
2013
-
Residue-level prediction of HIV-1 antibody epitopes based on neutralization of diverse viral strains..
87:10047-10058.
2013
-
High Levels of CD2 Expression Identify HIV-1 Latently Infected Resting Memory CD4+ T Cells in Virally Suppressed Subjects.
87:9148-9158.
2013
-
In vivo bioluminescent imaging of influenza a virus infection and characterization of novel cross-protective monoclonal antibodies..
87:8272-8281.
2013
-
Comparison of Viral Env Proteins from Acute and Chronic Infections with Subtype C Human Immunodeficiency Virus Type 1 Identifies Differences in Glycosylation and CCR5 Utilization and Suggests a New Strategy for Immunogen Design.
87:7218-7233.
2013
-
HIV-1 envelope glycoprotein trimers display open quaternary conformation when bound to the gp41 membrane-proximal external-region-directed broadly neutralizing antibody Z13e1..
87:7191-7196.
2013
-
Mutational inactivation of herpes simplex virus 1 microRNAs identifies viral mRNA targets and reveals phenotypic effects in culture..
87:6589-6603.
2013
-
A cluster of virus-encoded microRNAs accelerates acute systemic Epstein-Barr virus infection but does not significantly enhance virus-induced oncogenesis in vivo..
87:5437-5446.
2013
-
Antibody-DEPENDENT, FcγRI-mediated neutralization of HIV-1 in TZM-bl cells occurs independently of phagocytosis..
87:5287-5290.
2013
-
Dendritic cell immunoreceptor regulates Chikungunya virus pathogenesis in mice..
87:5697-5706.
2013
-
Identification of an HIV-1 clade A envelope that exhibits broad antigenicity and neutralization sensitivity and elicits antibodies targeting three distinct epitopes..
87:5372-5383.
2013
-
Immunogenicity of a vaccine regimen composed of simian immunodeficiency virus DNA, rMVA, and viral particles administered to female rhesus macaques via four different mucosal routes..
87:4738-4750.
2013
-
Biophysical and ultrastructural characterization of adeno-associated virus capsid uncoating and genome release..
87:2994-3002.
2013
-
Protection afforded by an HIV vaccine candidate in macaques depends on the dose of SIVmac251 at challenge exposure..
87:3538-3548.
2013
-
Antibodies with high avidity to the gp120 envelope protein in protection from simian immunodeficiency virus SIV(mac251) acquisition in an immunization regimen that mimics the RV-144 Thai trial..
87:1708-1719.
2013
-
Quantitative and qualitative differences in the T cell response to HIV in uninfected ugandans exposed or unexposed to HIV-infected partners.
87:9053-9063.
2013
-
Myeloid-derived suppressor cells regulate natural killer cell response to adenovirus-mediated gene transfer..
86:13689-13696.
2012
-
Analysis of Epstein-Barr virus-regulated host gene expression changes through primary B-cell outgrowth reveals delayed kinetics of latent membrane protein 1-mediated NF-κB activation..
86:11096-11106.
2012
-
Glycan binding avidity determines the systemic fate of adeno-associated virus type 9..
86:10408-10417.
2012
-
Memory CD4(+) T lymphocytes in the gastrointestinal tract are a major source of cell-associated simian immunodeficiency virus in chronic nonpathogenic infection of African green monkeys..
86:11380-11385.
2012
-
Pathogenicity and Mucosal Transmissibility of the R5-Tropic Simian/Human Immunodeficiency Virus SHIVAD8 in Rhesus Macaques: Implications for Use in Vaccine Studies.
86:8516-8526.
2012
-
Pathogenicity and mucosal transmissibility of the R5-tropic simian/human immunodeficiency virus SHIV(AD8) in rhesus macaques: implications for use in vaccine studies..
86:8516-8526.
2012
-
Single amino acid modification of adeno-associated virus capsid changes transduction and humoral immune profiles..
86:7752-7759.
2012
-
A novel variant marking HLA-DP expression levels predicts recovery from hepatitis B virus infection..
86:6979-6985.
2012
-
Human galectin 3 binding protein interacts with recombinant adeno-associated virus type 6..
86:6620-6631.
2012
-
The Epstein-Barr virus (EBV)-induced tumor suppressor microRNA MiR-34a is growth promoting in EBV-infected B cells..
86:6889-6898.
2012
-
Passively transmitted gp41 antibodies in babies born from HIV-1 subtype C-seropositive women: correlation between fine specificity and protection..
86:4129-4138.
2012
-
Replicating adenovirus-simian immunodeficiency virus (SIV) recombinant priming and envelope protein boosting elicits localized, mucosal IgA immunity in rhesus macaques correlated with delayed acquisition following a repeated low-dose rectal SIV(mac251) challenge..
86:4644-4657.
2012
-
Attenuation of neurovirulence, biodistribution, and shedding of a poliovirus:rhinovirus chimera after intrathalamic inoculation in Macaca fascicularis..
86:2750-2759.
2012
-
Control of innate immune signaling and membrane targeting by the Hepatitis C virus NS3/4A protease are governed by the NS3 helix α0..
86:3112-3120.
2012
-
Targeting HIV-1 envelope glycoprotein trimers to B cells by using APRIL improves antibody responses..
86:2488-2500.
2012
-
Engineering, expression, purification, and characterization of stable clade A/B recombinant soluble heterotrimeric gp140 proteins..
86:128-142.
2012
-
Targeted entry via somatostatin receptors using a novel modified retrovirus glycoprotein that delivers genes at levels comparable to those of wild-type viral glycoproteins..
86:373-381.
2012
-
Three-dimensional structures of soluble CD4-bound states of trimeric simian immunodeficiency virus envelope glycoproteins determined by using cryo-electron tomography..
85:12114-12123.
2011
-
Fitness costs and diversity of the cytotoxic T lymphocyte (CTL) response determine the rate of CTL escape during acute and chronic phases of HIV infection..
85:10518-10528.
2011
-
The members of an Epstein-Barr virus microRNA cluster cooperate to transform B lymphocytes..
85:9801-9810.
2011
-
HIV-specific functional antibody responses in breast milk mirror those in plasma and are primarily mediated by IgG antibodies..
85:9555-9567.
2011
-
High cell-free virus load and robust autologous humoral immune responses in breast milk of simian immunodeficiency virus-infected african green monkeys..
85:9517-9526.
2011
-
The genetic bottleneck in vertical transmission of subtype C HIV-1 is not driven by selection of especially neutralization-resistant virus from the maternal viral population..
85:8253-8262.
2011
-
Antibody-dependent cell-mediated cytotoxicity in simian immunodeficiency virus-infected rhesus monkeys..
85:6906-6912.
2011
-
Evolution of drug-resistant viral populations during interruption of antiretroviral therapy..
85:6403-6415.
2011
-
Immunization with recombinant HLA classes I and II, HIV-1 gp140, and SIV p27 elicits protection against heterologous SHIV infection in rhesus macaques..
85:6442-6452.
2011
-
Adaptation of an ICAM-1-tropic enterovirus to the mouse respiratory tract..
85:5606-5617.
2011
-
Significant protection against high-dose simian immunodeficiency virus challenge conferred by a new prime-boost vaccine regimen..
85:5764-5772.
2011
-
Clonal Sequences Recovered from Plasma from Patients with Residual HIV-1 Viremia and on Intensified Antiretroviral Therapy Are Identical to Replicating Viral RNAs Recovered from Circulating Resting CD4+ T Cells.
85:5220-5223.
2011
-
Origin and evolution of HIV-1 in breast milk determined by single-genome amplification and sequencing..
85:2751-2763.
2011
-
Characterization of glycosylation profiles of HIV-1 transmitted/founder envelopes by mass spectrometry.
85:8270-8284.
2011
-
Virally induced cellular microRNA miR-155 plays a key role in B-cell immortalization by Epstein-Barr virus..
84:11670-11678.
2010
-
Low-dose mucosal simian immunodeficiency virus infection restricts early replication kinetics and transmitted virus variants in rhesus monkeys..
84:10406-10412.
2010
-
Viral cell death inhibitor MC159 enhances innate immunity against vaccinia virus infection..
84:10467-10476.
2010
-
Limited contribution of mucosal IgA to Simian immunodeficiency virus (SIV)-specific neutralizing antibody response and virus envelope evolution in breast milk of SIV-infected, lactating rhesus monkeys..
84:8209-8218.
2010
-
Establishment of an H6N2 influenza virus lineage in domestic ducks in southern China..
84:6978-6986.
2010
-
HIV-1 resistance to CCR5 antagonists associated with highly efficient use of CCR5 and altered tropism on primary CD4+ T cells..
84:6505-6514.
2010
-
Wide variation in the multiplicity of HIV-1 infection among injection drug users..
84:6241-6247.
2010
-
A human herpesvirus microRNA inhibits p21 expression and attenuates p21-mediated cell cycle arrest..
84:5229-5237.
2010
-
Phenotypic and functional profile of HIV-inhibitory CD8 T cells elicited by natural infection and heterologous prime/boost vaccination..
84:4998-5006.
2010
-
Breadth of neutralizing antibodies elicited by stable, homogeneous clade A and clade C HIV-1 gp140 envelope trimers in guinea pigs..
84:3270-3279.
2010
-
Quaternary epitope specificities of anti-HIV-1 neutralizing antibodies generated in rhesus macaques infected by the simian/human immunodeficiency virus SHIVSF162P4..
84:3443-3453.
2010
-
Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies..
84:1439-1452.
2010
-
Associations between HLA class I alleles and escape mutations in the hepatitis B virus core gene in New Zealand-resident Tongans..
84:621-629.
2010
-
Herpes simplex virus proteins ICP27 and UL47 associate with polyadenylate-binding protein and control its subcellular distribution..
84:270-279.
2010
-
Identification of viral microRNAs expressed in human sacral ganglia latently infected with herpes simplex virus 2..
84:1189-1192.
2010
-
In-depth analysis of Kaposi's sarcoma-associated herpesvirus microRNA expression provides insights into the mammalian microRNA-processing machinery..
84:695-703.
2010
-
FAT10: a novel mediator of Vpr-induced apoptosis in human immunodeficiency virus-associated nephropathy..
83:11983-11988.
2009
-
Analysis of human alphaherpesvirus microRNA expression in latently infected human trigeminal ganglia..
83:10677-10683.
2009
-
Derivation and characterization of a simian immunodeficiency virus SIVmac239 variant with tropism for CXCR4..
83:9911-9922.
2009
-
Effect of B-cell depletion on viral replication and clinical outcome of simian immunodeficiency virus infection in a natural host..
83:10347-10357.
2009
-
Identification of ongoing human immunodeficiency virus type 1 (HIV-1) replication in residual viremia during recombinant HIV-1 poxvirus immunizations in patients with clinically undetectable viral loads on durable suppressive highly active antiretroviral therapy..
83:9731-9742.
2009
-
Stable docking of neutralizing human immunodeficiency virus type 1 gp41 membrane-proximal external region monoclonal antibodies 2F5 and 4E10 is dependent on the membrane immersion depth of their epitope regions..
83:10211-10223.
2009
-
Antibody specificities associated with neutralization breadth in plasma from human immunodeficiency virus type 1 subtype C-infected blood donors..
83:8925-8937.
2009
-
Protective efficacy of a single immunization of a chimeric adenovirus vector-based vaccine against simian immunodeficiency virus challenge in rhesus monkeys..
83:9584-9590.
2009
-
T-cell vaccine strategies for human immunodeficiency virus, the virus with a thousand faces..
83:8300-8314.
2009
-
Evidence that ecotropic murine leukemia virus contamination in TZM-bl cells does not affect the outcome of neutralizing antibody assays with human immunodeficiency virus type 1..
83:8289-8292.
2009
-
Pharmacovirological impact of an integrase inhibitor on human immunodeficiency virus type 1 cDNA species in vivo..
83:7706-7717.
2009
-
Utilization of immunoglobulin G Fc receptors by human immunodeficiency virus type 1: a specific role for antibodies against the membrane-proximal external region of gp41..
83:7397-7410.
2009
-
Cytotoxic-T-lymphocyte-mediated elimination of target cells transduced with engineered adeno-associated virus type 2 vector in vivo..
83:6817-6824.
2009
-
Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants (Journal of Virology (2009) 83, 8, (3556-3567)).
83:6974.
2009
-
Recombinant Mycobacterium bovis BCG prime-recombinant adenovirus boost vaccination in rhesus monkeys elicits robust polyfunctional simian immunodeficiency virus-specific T-cell responses..
83:5505-5513.
2009
-
Preclinical studies of human immunodeficiency virus/AIDS vaccines: inverse correlation between avidity of anti-Env antibodies and peak postchallenge viremia..
83:4102-4111.
2009
-
High specific infectivity of plasma virus from the pre-ramp-up and ramp-up stages of acute simian immunodeficiency virus infection..
83:3288-3297.
2009
-
In vivo gp41 antibodies targeting the 2F5 monoclonal antibody epitope mediate human immunodeficiency virus type 1 neutralization breadth..
83:3617-3625.
2009
-
Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants..
83:3556-3567.
2009
-
Expanded breadth of the T-cell response to mosaic human immunodeficiency virus type 1 envelope DNA vaccination..
83:2201-2215.
2009
-
MDM2-dependent inhibition of p53 is required for Epstein-Barr virus B-cell growth transformation and infected-cell survival..
83:2491-2499.
2009
-
Partial protection of Simian immunodeficiency virus (SIV)-infected rhesus monkeys against superinfection with a heterologous SIV isolate..
83:2686-2696.
2009
-
Neutralization-sensitive R5-tropic simian-human immunodeficiency virus SHIV-2873Nip, which carries env isolated from an infant with a recent HIV clade C infection..
83:1422-1432.
2009
-
Correlation of vaccine-elicited systemic and mucosal nonneutralizing antibody activities with reduced acute viremia following intrarectal simian immunodeficiency virus SIVmac251 challenge of rhesus macaques..
83:791-801.
2009
-
Equine infectious anemia virus resists the antiretroviral activity of equine APOBEC3 proteins through a packaging-independent mechanism..
82:11889-11901.
2008
-
Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia..
82:12449-12463.
2008
-
Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C..
82:11651-11668.
2008
-
Early B-cell activation after West Nile virus infection requires alpha/beta interferon but not antigen receptor signaling..
82:10964-10974.
2008
-
Improved induction of antibodies against key neutralizing epitopes by human immunodeficiency virus type 1 gp120 DNA prime-protein boost vaccination compared to gp120 protein-only vaccination..
82:7369-7378.
2008
-
Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design..
82:7700-7710.
2008
-
An engineered Saccharomyces cerevisiae strain binds the broadly neutralizing human immunodeficiency virus type 1 antibody 2G12 and elicits mannose-specific gp120-binding antibodies..
82:6447-6457.
2008
-
Antibody is critical for the clearance of murine norovirus infection..
82:6610-6617.
2008
-
Cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody that recognizes a novel conformational epitope on gp41 and lacks reactivity against self-antigens..
82:6869-6879.
2008
-
Human T-cell leukemia virus type 1 tax attenuates the ATM-mediated cellular DNA damage response..
82:6952-6961.
2008
-
Increased loss of CCR5+ CD45RA- CD4+ T cells in CD8+ lymphocyte-depleted Simian immunodeficiency virus-infected rhesus monkeys..
82:5618-5630.
2008
-
Surface loop dynamics in adeno-associated virus capsid assembly..
82:5178-5189.
2008
-
Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing..
82:3952-3970.
2008
-
Identification of the progenitors of Indonesian and Vietnamese avian influenza A (H5N1) viruses from southern China..
82:3405-3414.
2008
-
Human immunodeficiency virus type 1 gp41 antibodies that mask membrane proximal region epitopes: antibody binding kinetics, induction, and potential for regulation in acute infection..
82:115-125.
2008
-
Removal of a single N-linked glycan in human immunodeficiency virus type 1 gp120 results in an enhanced ability to induce neutralizing antibody responses..
82:638-651.
2008
-
Increased immunogenicity of a DNA-launched Venezuelan equine encephalitis virus-based replicon DNA vaccine..
81:13412-13423.
2007
-
Inhibition of alpharetrovirus replication by a range of human APOBEC3 proteins..
81:13694-13699.
2007
-
Analysis of the interaction of primate retroviruses with the human RNA interference machinery..
81:12218-12226.
2007
-
Incorporation of high levels of chimeric human immunodeficiency virus envelope glycoproteins into virus-like particles..
81:10869-10878.
2007
-
Murine noroviruses comprising a single genogroup exhibit biological diversity despite limited sequence divergence..
81:10460-10473.
2007
-
The genesis and evolution of H9N2 influenza viruses in poultry from southern China, 2000 to 2005..
81:10389-10401.
2007
-
Evidence of Viral Adaptation to HLA Class I-Restricted Immune Pressure in Chronic Hepatitis C Virus Infection.
81:8846-8848.
2007
-
Genetic adaptation to untranslated region-mediated enterovirus growth deficits by mutations in the nonstructural proteins 3AB and 3CD..
81:8396-8405.
2007
-
Heterologous prime/boost immunization of rhesus monkeys by using diverse poxvirus vectors..
81:8563-8570.
2007
-
Memory CD4+ T-lymphocyte loss and dysfunction during primary simian immunodeficiency virus infection..
81:8009-8015.
2007
-
Adeno-associated virus type 2 (AAV2) capsid-specific cytotoxic T lymphocytes eliminate only vector-transduced cells coexpressing the AAV2 capsid in vivo..
81:7540-7547.
2007
-
Characterization of low-pathogenic H5 subtype influenza viruses from Eurasia: implications for the origin of highly pathogenic H5N1 viruses..
81:7529-7539.
2007
-
Detection of a novel and highly divergent coronavirus from asian leopard cats and Chinese ferret badgers in Southern China..
81:6920-6926.
2007
-
Generation of infectious molecular clones of simian immunodeficiency virus from fecal consensus sequences of wild chimpanzees..
81:7463-7475.
2007
-
Location and role of free cysteinyl residues in the Sindbis virus E1 and E2 glycoproteins..
81:6231-6240.
2007
-
The DNA binding domain of a papillomavirus E2 protein programs a chimeric nuclease to cleave integrated human papillomavirus DNA in HeLa cervical carcinoma cells..
81:6254-6264.
2007
-
Antiviral antibodies are necessary for control of simian immunodeficiency virus replication..
81:5024-5035.
2007
-
Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques..
81:5257-5269.
2007
-
A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques..
81:3414-3427.
2007
-
Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and -independent pathways..
81:3170-3180.
2007
-
Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity..
81:3487-3494.
2007
-
Phylogenetic analysis of feline immunodeficiency virus in feral and companion domestic cats of New Zealand..
81:2999-3004.
2007
-
Adenovirus infection triggers a rapid, MyD88-regulated transcriptome response critical to acute-phase and adaptive immune responses in vivo..
81:1796-1812.
2007
-
Attenuation of herpes simplex virus neurovirulence with picornavirus cis-acting genetic elements..
81:791-799.
2007
-
Rapid memory CD8+ T-lymphocyte induction through priming with recombinant Mycobacterium smegmatis..
81:74-83.
2007
-
Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa..
80:11776-11790.
2006
-
Human immunodeficiency virus type 1 resistance to the small molecule maturation inhibitor 3-O-(3',3'-dimethylsuccinyl)-betulinic acid is conferred by a variety of single amino acid substitutions at the CA-SP1 cleavage site in Gag..
80:12095-12101.
2006
-
The betaretrovirus Mason-Pfizer monkey virus selectively excludes simian APOBEC3G from virion particles..
80:12102-12108.
2006
-
Evidence of viral adaptation to HLA class I-restricted immune pressure in chronic hepatitis C virus infection..
80:11094-11104.
2006
-
Human papillomavirus genotype 31 does not express detectable microRNA levels during latent or productive virus replication..
80:10890-10893.
2006
-
Single amino acid changes can influence titer, heparin binding, and tissue tropism in different adeno-associated virus serotypes..
80:11393-11397.
2006
-
Adeno-associated virus type 2 contains an integrin alpha5beta1 binding domain essential for viral cell entry..
80:8961-8969.
2006
-
Feline Lentivirus Evolution in Cross-Species Infection Reveals Extensive G-to-A Mutation and Selection on Key Residues in the Viral Polymerase.
80:8845-8845.
2006
-
Integration Site Choice of a Feline Immunodeficiency Virus Vector.
80:8820-8823.
2006
-
Novel function of prothymosin alpha as a potent inhibitor of human immunodeficiency virus type 1 gene expression in primary macrophages..
80:9200-9206.
2006
-
Poxvirus tumor necrosis factor receptor (TNFR)-like T2 proteins contain a conserved preligand assembly domain that inhibits cellular TNFR1-induced cell death..
80:9300-9309.
2006
-
Cross-subtype T-cell immune responses induced by a human immunodeficiency virus type 1 group m consensus env immunogen..
80:6745-6756.
2006
-
Structured treatment interruptions with tenofovir monotherapy for simian immunodeficiency virus-infected newborn macaques..
80:6399-6410.
2006
-
The double-stranded RNA binding protein 76:NF45 heterodimer inhibits translation initiation at the rhinovirus type 2 internal ribosome entry site..
80:6936-6942.
2006
-
A novel assay for viral microRNA function identifies a single nucleotide polymorphism that affects Drosha processing..
80:5321-5326.
2006
-
Cell-type-specific repression of internal ribosome entry site activity by double-stranded RNA-binding protein 76..
80:3147-3156.
2006
-
Competitive translation efficiency at the picornavirus type 1 internal ribosome entry site facilitated by viral cis and trans factors..
80:3310-3321.
2006
-
Systemic immunization with an ALVAC-HIV-1/protein boost vaccine strategy protects rhesus macaques from CD4+ T-cell loss and reduces both systemic and mucosal simian-human immunodeficiency virus SHIVKU2 RNA levels..
80:3732-3742.
2006
-
Feline Lentivirus Evolution in Cross-Species Infection Reveals Extensive G-to-A Mutation and Selection on Key Residues in the Viral Polymerase.
80:2728-2737.
2006
-
Transcriptional origin of Kaposi's sarcoma-associated herpesvirus microRNAs..
80:2234-2242.
2006
-
Generation of CD8+ T-cell responses by a recombinant nonpathogenic Mycobacterium smegmatis vaccine vector expressing human immunodeficiency virus type 1 Env..
80:1645-1652.
2006
-
Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors..
80:1067-1076.
2006
-
A combination DNA and attenuated simian immunodeficiency virus vaccine strategy provides enhanced protection from simian/human immunodeficiency virus-induced disease..
79:15356-15367.
2005
-
Induction of neutralizing antibodies against human immunodeficiency virus type 1 primary isolates by Gag-Env pseudovirion immunization..
79:14804-14814.
2005
-
Complex determinants in human immunodeficiency virus type 1 envelope gp120 mediate CXCR4-dependent infection of macrophages..
79:13250-13261.
2005
-
Effect of alternating passage on adaptation of sindbis virus to vertebrate and invertebrate cells..
79:14253-14260.
2005
-
Evaluation of envelope vaccines derived from the South African subtype C human immunodeficiency virus type 1 TV1 strain..
79:13338-13349.
2005
-
Human immunodeficiency virus type 1 subtype B ancestral envelope protein is functional and elicits neutralizing antibodies in rabbits similar to those elicited by a circulating subtype B envelope..
79:11214-11224.
2005
-
Multiple gene segments control the temperature sensitivity and attenuation phenotypes of ca B/Ann Arbor/1/66..
79:11014-11021.
2005
-
Variation in interferon sensitivity and induction among strains of eastern equine encephalitis virus..
79:11300-11310.
2005
-
Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies..
79:10108-10125.
2005
-
Replicating rather than nonreplicating adenovirus-human immunodeficiency virus recombinant vaccines are better at eliciting potent cellular immunity and priming high-titer antibodies..
79:10200-10209.
2005
-
DNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challenge..
79:8480-8492.
2005
-
Differential sensitivity of murine leukemia virus to APOBEC3-mediated inhibition is governed by virion exclusion..
79:8201-8207.
2005
-
Effect of CD8+ lymphocyte depletion on virus containment after simian immunodeficiency virus SIVmac251 challenge of live attenuated SIVmac239delta3-vaccinated rhesus macaques..
79:8131-8141.
2005
-
Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors..
79:8724-8731.
2005
-
Pathogenicity of simian-human immunodeficiency virus SHIV-89.6P and SIVmac is attenuated in cynomolgus macaques and associated with early T-lymphocyte responses..
79:8878-8885.
2005
-
Enhanced immunogenicity of gp120 protein when combined with recombinant DNA priming to generate antibodies that neutralize the JR-FL primary isolate of human immunodeficiency virus type 1..
79:7933-7937.
2005
-
Genetic determinants of cell type-specific poliovirus propagation in HEK 293 cells..
79:6281-6290.
2005
-
The polypyrimidine tract binding protein is required for efficient picornavirus gene expression and propagation..
79:6172-6179.
2005
-
Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cells..
79:3358-3369.
2005
-
Signature for long-term vaccine-mediated control of a Simian and human immunodeficiency virus 89.6P challenge: stable low-breadth and low-frequency T-cell response capable of coproducing gamma interferon and interleukin-2..
79:3243-3253.
2005
-
Antigenicity and immunogenicity of a synthetic human immunodeficiency virus type 1 group m consensus envelope glycoprotein..
79:1154-1163.
2005
-
Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteins..
79:771-779.
2005
-
Novel adeno-associated virus vector vaccine restricts replication of simian immunodeficiency virus in macaques..
79:955-965.
2005
-
Adenovirus VA1 noncoding RNA can inhibit small interfering RNA and MicroRNA biogenesis..
78:12868-12876.
2004
-
Efficacy of DNA and fowlpox virus priming/boosting vaccines for simian/human immunodeficiency virus..
78:13819-13828.
2004
-
Gender differences in human immunodeficiency virus type 1-specific CD8 responses in the reproductive tract and colon following nasal peptide priming and modified vaccinia virus Ankara boosting..
78:13163-13172.
2004
-
Immunogenicity study of glycoprotein-deficient rabies virus expressing simian/human immunodeficiency virus SHIV89.6P envelope in a rhesus macaque..
78:13455-13459.
2004
-
Further investigation of simian immunodeficiency virus Vif function in human cells..
78:12041-12046.
2004
-
Impact on genetic networks in human macrophages by a CCR5 strain of human immunodeficiency virus type 1..
78:11477-11486.
2004
-
Genetic relationships and evolution of genotypes of yellow fever virus and other members of the yellow fever virus group within the Flavivirus genus based on the 3' noncoding region..
78:9652-9665.
2004
-
Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody..
78:9233-9242.
2004
-
Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys..
78:7490-7497.
2004
-
New simian immunodeficiency virus infecting De Brazza's monkeys (Cercopithecus neglectus): evidence for a cercopithecus monkey virus clade..
78:7748-7762.
2004
-
Passive immunotherapy in simian immunodeficiency virus-infected macaques accelerates the development of neutralizing antibodies..
78:5983-5995.
2004
-
Cross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroups..
78:4421-4432.
2004
-
Immunogenicity of constrained monoclonal antibody A32-human immunodeficiency virus (HIV) Env gp120 complexes compared to that of recombinant HIV type 1 gp120 envelope glycoproteins..
78:5270-5278.
2004
-
Inability of Simian Virus 40 To Establish Productive Infection of Lymphoblastic Cell Lines.
78:4917-4920.
2004
-
Correlation between env V1/V2 region diversification and neutralizing antibodies during primary infection by simian immunodeficiency virus sm in rhesus macaques..
78:3561-3571.
2004
-
Highly effective control of an AIDS virus challenge in macaques by using vesicular stomatitis virus and modified vaccinia virus Ankara vaccine vectors in a single-boost protocol..
78:3930-3940.
2004
-
Repression of the human papillomavirus E6 gene initiates p53-dependent, telomerase-independent senescence and apoptosis in HeLa cervical carcinoma cells..
78:4063-4073.
2004
-
Unselected mutations in the human immunodeficiency virus type 1 genome are mostly nonsynonymous and often deleterious..
78:2426-2433.
2004
-
Immune failure in the absence of profound CD4+ T-lymphocyte depletion in simian immunodeficiency virus-infected rapid progressor macaques..
78:275-284.
2004
-
Small-molecule inhibition of human immunodeficiency virus type 1 replication by specific targeting of the final step of virion maturation..
78:922-929.
2004
-
Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239..
77:13348-13360.
2003
-
Inhibition of human immunodeficiency virus type 1 replication in primary macrophages by using Tat- or CCR5-specific small interfering RNAs expressed from a lentivirus vector..
77:11964-11972.
2003
-
Cellular immunity elicited by human immunodeficiency virus type 1/ simian immunodeficiency virus DNA vaccination does not augment the sterile protection afforded by passive infusion of neutralizing antibodies..
77:10348-10356.
2003
-
Effects of human metapneumovirus and respiratory syncytial virus antigen insertion in two 3' proximal genome positions of bovine/human parainfluenza virus type 3 on virus replication and immunogenicity..
77:10819-10828.
2003
-
Purification, characterization, and immunogenicity of a soluble trimeric envelope protein containing a partial deletion of the V2 loop derived from SF162, an R5-tropic human immunodeficiency virus type 1 isolate..
77:11244-11259.
2003
-
Epidemiology, genetic diversity, and evolution of endemic feline immunodeficiency virus in a population of wild cougars..
77:9578-9589.
2003
-
Improved protection of rhesus macaques against intrarectal simian immunodeficiency virus SIV(mac251) challenge by a replication-competent Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinant priming/gp120 boosting regimen..
77:8354-8365.
2003
-
Major histocompatibility complex class I alleles associated with slow simian immunodeficiency virus disease progression bind epitopes recognized by dominant acute-phase cytotoxic-T-lymphocyte responses..
77:9029-9040.
2003
-
Foci of endemic simian immunodeficiency virus infection in wild-living eastern chimpanzees (Pan troglodytes schweinfurthii)..
77:7545-7562.
2003
-
Increased thymic output during acute measles virus infection..
77:7872-7879.
2003
-
CAF-mediated human immunodeficiency virus (HIV) type 1 transcriptional inhibition is distinct from alpha-defensin-1 HIV inhibition..
77:6777-6784.
2003
-
Dual pressure from antiretroviral therapy and cell-mediated immune response on the human immunodeficiency virus type 1 protease gene..
77:6743-6752.
2003
-
RNA interference of human papillomavirus type 18 E6 and E7 induces senescence in HeLa cells..
77:6066-6069.
2003
-
Role of CD8(+) lymphocytes in control and clearance of measles virus infection of rhesus monkeys..
77:4396-4400.
2003
-
Loss of the perforin cytotoxic pathway predisposes mice to experimental cytomegalovirus retinitis..
77:3402-3408.
2003
-
Simian-human immunodeficiency virus SHIV89.6-induced protection against intravaginal challenge with pathogenic SIVmac239 is independent of the route of immunization and is associated with a combination of cytotoxic T-lymphocyte and alpha interferon responses..
77:3099-3118.
2003
-
Amplification of a complete simian immunodeficiency virus genome from fecal RNA of a wild chimpanzee..
77:2233-2242.
2003
-
Effect of humoral immune responses on controlling viremia during primary infection of rhesus monkeys with simian immunodeficiency virus..
77:2165-2173.
2003
-
Enhancement of antibodies to the human immunodeficiency virus type 1 envelope by using the molecular adjuvant C3d..
77:2046-2055.
2003
-
Phosphatidylinositol 3-kinase regulates human immunodeficiency virus type 1 replication following viral entry in primary CD4+ T lymphocytes and macrophages..
77:2539-2549.
2003
-
Glycosaminoglycan binding properties of natural venezuelan equine encephalitis virus isolates..
77:1204-1210.
2003
-
Marker rescue of adeno-associated virus (AAV) capsid mutants: a novel approach for chimeric AAV production..
77:423-432.
2003
-
Prevention of disease induced by a partially heterologous AIDS virus in rhesus monkeys by using an adjuvanted multicomponent protein vaccine..
77:1049-1058.
2003
-
Role of the asialoglycoprotein receptor in binding and entry of hepatitis C virus structural proteins in cultured human hepatocytes..
77:546-559.
2003
-
Identification of the orthopoxvirus p4c gene, which encodes a structural protein that directs intracellular mature virus particles into A-type inclusions..
76:11216-11225.
2002
-
Immune-mediated positive selection drives human immunodeficiency virus type 1 molecular variation and predicts disease duration..
76:11715-11720.
2002
-
Live, attenuated simian immunodeficiency virus SIVmac-M4, with point mutations in the Env transmembrane protein intracytoplasmic domain, provides partial protection from mucosal challenge with pathogenic SIVmac251..
76:11365-11378.
2002
-
Mandelic acid condensation polymer: novel candidate microbicide for prevention of human immunodeficiency virus and herpes simplex virus entry..
76:11236-11244.
2002
-
Selection for human immunodeficiency virus type 1 recombinants in a patient with rapid progression to AIDS..
76:10674-10684.
2002
-
Effects of cytotoxic T lymphocytes (CTL) directed against a single simian immunodeficiency virus (SIV) Gag CTL epitope on the course of SIVmac239 infection..
76:10507-10511.
2002
-
Elevated chemokine responses are maintained in lungs after clearance of viral infection..
76:10518-10523.
2002
-
In Vivo Gene Transfer Using a Nonprimate Lentiviral Vector Pseudotyped with Ross River Virus Glycoproteins.
76:9378-9388.
2002
-
Generation of neutralizing activity against human immunodeficiency virus type 1 in serum by antibody gene transfer..
76:8769-8775.
2002
-
Genetically stable picornavirus expression vectors with recombinant internal ribosomal entry sites..
76:8966-8972.
2002
-
Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference..
76:9225-9231.
2002
-
Different patterns of immune responses but similar control of a simian-human immunodeficiency virus 89.6P mucosal challenge by modified vaccinia virus Ankara (MVA) and DNA/MVA vaccines..
76:7625-7631.
2002
-
Favorable and unfavorable HLA class I alleles and haplotypes in Zambians predominantly infected with clade C human immunodeficiency virus type 1..
76:8276-8284.
2002
-
Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239..
76:7187-7202.
2002
-
Critical role for Env as well as Gag-Pol in control of a simian-human immunodeficiency virus 89.6P challenge by a DNA prime/recombinant modified vaccinia virus Ankara vaccine..
76:6138-6146.
2002
-
Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization..
76:5357-5368.
2002
-
Molecular evolution of human immunodeficiency virus env in humans and monkeys: similar patterns occur during natural disease progression or rapid virus passage..
76:5278-5284.
2002
-
Recruitment of the Crm1 nuclear export factor is sufficient to induce cytoplasmic expression of incompletely spliced human immunodeficiency virus mRNAs..
76:2036-2042.
2002
-
Regional clustering of shared neutralization determinants on primary isolates of clade C human immunodeficiency virus type 1 from South Africa..
76:2233-2244.
2002
-
A soluble factor(s) secreted from CD8(+) T lymphocytes inhibits human immunodeficiency virus type 1 replication through STAT1 activation..
76:569-581.
2002
-
ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency..
76:292-302.
2002
-
Cytokines as adjuvants for the induction of anti-human immunodeficiency virus peptide immunoglobulin G (IgG) and IgA antibodies in serum and mucosal secretions after nasal immunization..
76:517-524.
2002
-
Molecular epidemiology of human immunodeficiency virus type 1 transmission in a heterosexual cohort of discordant couples in Zambia..
76:397-405.
2002
-
Rev-independent simian immunodeficiency virus strains are nonpathogenic in neonatal macaques..
76:96-104.
2002
-
NF-kappaB cis-acting motifs of the human immunodeficiency virus (HIV) long terminal repeat regulate HIV transcription in human macrophages..
75:11408-11416.
2001
-
Neutralizing antibodies associated with viremia control in a subset of individuals after treatment of acute human immunodeficiency virus type 1 infection..
75:10200-10207.
2001
-
Jaagsiekte Sheep Retrovirus Env Protein Stabilizes Retrovirus Vectors against Inactivation by Lung Surfactant, Centrifugation, and Freeze-Thaw Cycling.
75:8864-8867.
2001
-
Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T-lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines..
75:8681-8689.
2001
-
Inhibition of human immunodeficiency virus type 1 transcription by chemical cyclin-dependent kinase inhibitors..
75:7266-7279.
2001
-
Molecular basis for cell tropism of CXCR4-dependent human immunodeficiency virus type 1 isolates..
75:6776-6785.
2001
-
Postnatal passive immunization of neonatal macaques with a triple combination of human monoclonal antibodies against oral simian-human immunodeficiency virus challenge..
75:7470-7480.
2001
-
The R region found in the human foamy virus long terminal repeat is critical for both Gag and Pol protein expression..
75:6817-6824.
2001
-
Wild Mandrillus sphinx are carriers of two types of lentivirus..
75:7086-7096.
2001
-
Induction and characterization of neutralizing antibodies against a human immunodeficiency virus type 1 primary isolate..
75:6700-6704.
2001
-
Induction of neutralizing antibodies and gag-specific cellular immune responses to an R5 primary isolate of human immunodeficiency virus type 1 in rhesus macaques..
75:5879-5890.
2001
-
Potential sources of the 1995 Venezuelan equine encephalitis subtype IC epidemic..
75:5823-5832.
2001
-
Reduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccination..
75:5151-5158.
2001
-
Relationships between CD4 independence, neutralization sensitivity, and exposure of a CD4-induced epitope in a human immunodeficiency virus type 1 envelope protein..
75:5230-5239.
2001
-
Vaccine-elicited V3 loop-specific antibodies in rhesus monkeys and control of a simian-human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate envelope..
75:4165-4175.
2001
-
Differential CD4/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate..
75:3568-3580.
2001
-
RNA replication from the simian virus 5 antigenomic promoter requires three sequence-dependent elements separated by sequence-independent spacer regions..
75:3993-3998.
2001
-
Polyvalent envelope glycoprotein vaccine elicits a broader neutralizing antibody response but is unable to provide sterilizing protection against heterologous Simian/human immunodeficiency virus infection in pigtailed macaques..
75:2224-2234.
2001
-
Functional analysis of the simian immunodeficiency virus Vpx protein: identification of packaging determinants and a novel nuclear targeting domain..
75:362-374.
2001
-
Immunogenicity and protective efficacy of oligomeric human immunodeficiency virus type 1 gp140..
75:645-653.
2001
-
In vivo attenuation of simian immunodeficiency virus by disruption of a tyrosine-dependent sorting signal in the envelope glycoprotein cytoplasmic tail..
75:278-291.
2001
-
Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells..
74:9868-9877.
2000
-
Testing the hypothesis of a recombinant origin of human immunodeficiency virus type 1 subtype E..
74:10752-10765.
2000
-
Effects of genital tract inflammation on human immunodeficiency virus type 1 V3 populations in blood and semen..
74:8946-8952.
2000
-
Identification of gp120 regions targeted by a highly potent neutralizing antiserum elicited in a chimpanzee inoculated with a primary human immunodeficiency virus type 1 isolate.
74:9749-9754.
2000
-
Mutational definition of functional domains within the Rev homolog encoded by human endogenous retrovirus K..
74:9353-9361.
2000
-
Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection: control of viral replication and absence of persistent HIV-1-specific immune responses..
74:6984-6991.
2000
-
Analysis of cellular factors that mediate nuclear export of RNAs bearing the Mason-Pfizer monkey virus constitutive transport element..
74:5863-5871.
2000
-
Clinical isolates of measles virus use CD46 as a cellular receptor..
74:3967-3974.
2000
-
Functional differences between human and bovine immunodeficiency virus Tat transcription factors..
74:4666-4671.
2000
-
Evolutionary relationships of endemic/epidemic and sylvatic dengue viruses..
74:3227-3234.
2000
-
Partial rescue of the Vif-negative phenotype of mutant human immunodeficiency virus type 1 strains from nonpermissive cells by intravirion reverse transcription..
74:2594-2602.
2000
-
Recombinant modified vaccinia virus ankara expressing the surface gp120 of simian immunodeficiency virus (SIV) primes for a rapid neutralizing antibody response to SIV infection in macaques..
74:2960-2965.
2000
-
Characterization of the trans-activation properties of equine herpesvirus 1 EICP0 protein.
74:1200-1208.
2000
-
Induction of antibodies in guinea pigs and rhesus monkeys against the human immunodeficiency virus type 1 envelope: neutralization of nonpathogenic and pathogenic primary isolate simian/human immunodeficiency virus strains..
74:254-263.
2000
-
Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles..
74:371-378.
2000
-
Characterization of primary isolate-like variants of simian-human immunodeficiency virus..
73:10199-10207.
1999
-
Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection..
73:10489-10502.
1999
-
Determinants of CD4 independence for a human immunodeficiency virus type 1 variant map outside regions required for coreceptor specificity..
73:10310-10319.
1999
-
Protection by live, attenuated simian immunodeficiency virus against heterologous challenge..
73:8356-8363.
1999
-
Role of immune responses against the envelope and the core antigens of simian immunodeficiency virus SIVmne in protection against homologous cloned and uncloned virus challenge in Macaques..
73:8201-8215.
1999
-
Analysis of the effect of natural sequence variation in Tat and in cyclin T on the formation and RNA binding properties of Tat-cyclin T complexes..
73:5777-5786.
1999
-
Lack of viral escape and defective in vivo activation of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes in rapidly progressive infection..
73:5509-5519.
1999
-
Highly attenuated vaccine strains of simian immunodeficiency virus protect against vaginal challenge: inverse relationship of degree of protection with level of attenuation..
73:4952-4961.
1999
-
Genetic and phenotypic changes accompanying the emergence of epizootic subtype IC Venezuelan equine encephalitis viruses from an enzootic subtype ID progenitor..
73:4266-4271.
1999
-
Protection of macaques against intrarectal infection by a combination immunization regimen with recombinant simian immunodeficiency virus SIVmne gp160 vaccines..
73:3134-3146.
1999
-
Residues critical for duck hepatitis B virus neutralization are involved in host cell interaction..
73:2569-2575.
1999
-
Dual stem loops within the poliovirus internal ribosomal entry site control neurovirulence..
73:958-964.
1999
-
Limited breadth of the protective immunity elicited by simian immunodeficiency virus SIVmne gp160 vaccines in a combination immunization regimen..
73:618-630.
1999
-
Nuclear magnetic resonance analysis of solution conformations in C4-V3 hybrid peptides derived from human immunodeficiency virus (HIV) type 1 gp120: relation to specificity of peptide-induced anti-HIV neutralizing antibodies..
73:746-750.
1999
-
RNA replication for the paramyxovirus simian virus 5 requires an internal repeated (CGNNNN) sequence motif..
73:805-809.
1999
-
An isolate of human immunodeficiency virus type 1 originally classified as subtype I represents a complex mosaic comprising three different group M subtypes (A, G, and I)..
72:10234-10241.
1998
-
Localization of a baculovirus-induced chitinase in the insect cell endoplasmic reticulum..
72:10207-10212.
1998
-
Inhibition of human immunodeficiency virus Rev and human T-cell leukemia virus Rex function, but not Mason-Pfizer monkey virus constitutive transport element activity, by a mutant human nucleoporin targeted to Crm1..
72:8627-8635.
1998
-
Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 Env antibody elicited by DNA priming and protein boosting..
72:9092-9100.
1998
-
Evolution of envelope sequences from the genital tract and peripheral blood of women infected with clade A human immunodeficiency virus type 1..
72:8240-8251.
1998
-
Temporal analyses of virus replication, immune responses, and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine..
72:7501-7509.
1998
-
Neutralizing antibodies in sera from macaques immunized with attenuated simian immunodeficiency virus..
72:6950-6955.
1998
-
A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1..
72:5680-5698.
1998
-
A small yeast RNA blocks hepatitis C virus internal ribosome entry site (HCV IRES)-mediated translation and inhibits replication of a chimeric poliovirus under translational control of the HCV IRES element..
72:5638-5647.
1998
-
Derivation and functional characterization of a consensus DNA binding sequence for the tas transcriptional activator of simian foamy virus type 1..
72:5502-5509.
1998
-
Genetically divergent strains of human immunodeficiency virus type 2 use multiple coreceptors for viral entry..
72:5425-5432.
1998
-
Expression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1..
72:4962-4969.
1998
-
Mechanism of injury-provoked poliomyelitis..
72:5056-5060.
1998
-
Recombinant vaccine-induced protection against the highly pathogenic simian immunodeficiency virus SIV(mac251): dependence on route of challenge exposure..
72:4170-4182.
1998
-
Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers..
72:4212-4223.
1998
-
Neutralizing antibodies in sera from macaques infected with chimeric simian-human immunodeficiency virus containing the envelope glycoproteins of either a laboratory-adapted variant or a primary isolate of human immunodeficiency virus type 1..
72:3427-3431.
1998
-
Evidence that antibody-mediated neutralization of human immunodeficiency virus type 1 by sera from infected individuals is independent of coreceptor usage..
72:1886-1893.
1998
-
Multiple residues contribute to the inability of murine CCR-5 to function as a coreceptor for macrophage-tropic human immunodeficiency virus type 1 isolates..
72:1918-1924.
1998
-
CD4+-T-cell and CD20+-B-cell changes predict rapid disease progression after simian-human immunodeficiency virus infection in macaques..
72:1600-1605.
1998
-
Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines..
72:1552-1576.
1998
-
Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted..
72:926-933.
1998
-
A functional antigenomic promoter for the paramyxovirus simian virus 5 requires proper spacing between an essential internal segment and the 3' terminus..
72:10-19.
1998
-
CBF, Myb, and Ets binding sites are important for activity of the core I element of the murine retrovirus SL3-3 in T lymphocytes.
72:3129-3137.
1998
-
Erratum: A small yeast RNA blocks hepatitis C virus internal ribosome entry site (HCV IRES)-mediated translation and inhibits replication of a chimeric poliovirus under translational control of the HCV IRES element (Journal of Virology (1998) 72:7 (5638-5647)).
72:9419.
1998
-
Identification and functional characterization of a high-affinity Bel-1 DNA binding site located in the human foamy virus internal promoter..
72:504-511.
1998
-
Natural infection of a household pet red-capped mangabey (Cercocebus torquatus torquatus) with a new simian immunodeficiency virus..
72:600-608.
1998
-
Simian immunodeficiency virus (SIV) envelope-specific Fabs with high-level homologous neutralizing activity: recovery from a long-term-nonprogressor SIV-infected macaque..
72:585-592.
1998
-
Viral genetic evolution in macaques infected with molecularly cloned simian immunodeficiency virus correlates withthe extent of persistent viremia.
72:6482-6489.
1998
-
Rotavirus RNA polymerase requires the core shell protein to synthesize the double-stranded RNA genome..
71:9618-9626.
1997
-
Cross-clade human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte responses in HIV-infected Zambians..
71:8908-8911.
1997
-
Human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus Nef use distinct but overlapping target sites for downregulation of cell surface CD4..
71:6742-6748.
1997
-
Murine CXCR-4 is a functional coreceptor for T-cell-tropic and dual-tropic strains of human immunodeficiency virus type 1..
71:7097-7100.
1997
-
Genetic diversity of feline immunodeficiency virus: dual infection, recombination, and distinct evolutionary rates among envelope sequence clades..
71:4241-4253.
1997
-
Evolution and probable transmission of intersubtype recombinant human immunodeficiency virus type 1 in a Zambian couple..
71:2647-2655.
1997
-
Antibody-mediated neutralization of primary isolates of human immunodeficiency virus type 1 in peripheral blood mononuclear cells is not affected by the initial activation state of the cells..
71:2512-2517.
1997
-
A molecularly cloned, pathogenic, neutralization-resistant simian immunodeficiency virus, SIVsmE543-3..
71:1608-1620.
1997
-
Overlapping epitopes in human immunodeficiency virus type 1 gp120 presented by HLA A, B, and C molecules: effects of viral variation on cytotoxic T-lymphocyte recognition..
71:1256-1264.
1997
-
Importance of a c-Myb binding site for lymphomagenesis by the retrovirus SL3-3.
71:1213-1219.
1997
-
Molecular analysis of the feline immunodeficiency virus protease: Generation of a novel form of the protease by autoproteolysis and construction of cleavage-resistant proteases.
71:5505-5511.
1997
-
The ICP0 protein of equine herpesvirus 1 is an early protein that independently transactivates expression of all classes of viral promoters.
71:4904-4914.
1997
-
Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy..
70:8934-8943.
1996
-
The human cytomegalovirus IE1-72 protein interacts with the cellular p107 protein and relieves p107-mediated transcriptional repression of an E2F-responsive promoter..
70:7867-7877.
1996
-
Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs..
70:7209-7212.
1996
-
The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin..
70:7013-7029.
1996
-
Transient subversion of CD40 ligand function diminishes immune responses to adenovirus vectors in mouse liver and lung tissues..
70:6370-6377.
1996
-
Inhibition of nitric oxide synthesis increases mortality in Sindbis virus encephalitis..
70:3972-3977.
1996
-
Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara..
70:3741-3752.
1996
-
Simian immunodeficiency virus DNA vaccine trial in macaques..
70:3978-3991.
1996
-
The human foamy virus Bel-1 transcription factor is a sequence-specific DNA binding protein..
70:3902-3908.
1996
-
Vaccine protection by a triple deletion mutant of simian immunodeficiency virus..
70:3724-3733.
1996
-
An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys..
70:3198-3206.
1996
-
n-Butyrate, a cell cycle blocker, inhibits early amplification of duck hepatitis B virus covalently closed circular DNA after in vitro infection of duck hepatocytes..
70:2691-2696.
1996
-
Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization..
70:1651-1667.
1996
-
Sequences within a small yeast RNA required for inhibition of internal initiation of translation: interaction with La and other cellular proteins influences its inhibitory activity..
70:1624-1632.
1996
-
Mutations of basic amino acids of NCp7 of human immunodeficiency virus type 1 affect RNA binding in vitro..
70:771-777.
1996
-
Increased envelope spike density and stability are not required for the neutralization resistance of primary human immunodeficiency viruses.
70:6136-6142.
1996
-
Sequences flanking the pentanucleotide T-antigen binding sites in the polyomavirus core origin help determine selectivity of DNA replication..
69:7570-7578.
1995
-
Immunogenic determinants of a neuropathogenic murine leukemia virus..
69:6847-6851.
1995
-
Potent inhibition of human immunodeficiency virus type 1 (HIV-1) replication by inducible expression of HIV-1 PR multimers..
69:5988-5994.
1995
-
Sp1 transcription factor is required for in vitro basal and Tat-activated transcription from the human immunodeficiency virus type 1 long terminal repeat..
69:6572-6576.
1995
-
Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1..
69:6239-6248.
1995
-
A human recombinant Fab identifies a human immunodeficiency virus type 1-induced conformational change in cell surface-expressed CD4..
69:5734-5742.
1995
-
A single amino acid change in the cytoplasmic domain of the simian immunodeficiency virus transmembrane molecule increases envelope glycoprotein expression on infected cells..
69:5217-5227.
1995
-
Persistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic individual..
69:5743-5753.
1995
-
Cellular CD44S as a determinant of human immunodeficiency virus type 1 infection and cellular tropism..
69:4000-4005.
1995
-
A molecular clasp in the human immunodeficiency virus (HIV) type 1 TM protein determines the anti-HIV activity of gp41 derivatives: implication for viral fusion..
69:3771-3777.
1995
-
Transcriptional trans activation by human immunodeficiency virus type 1 Tat requires specific coactivators that are not basal factors..
69:3098-3107.
1995
-
Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses..
69:2004-2015.
1995
-
Direct interactions between autoantigen La and human immunodeficiency virus leader RNA..
69:618-619.
1995
-
Erratum: Direct interactions between autoantigen La and human immunodeficiency virus leader RNA (Journal of Virology 68:11 (7014)).
69:618-619.
1995
-
Direct interactions between autoantigen La and human immunodeficiency virus leader RNA..
68:7008-7020.
1994
-
Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology..
68:7433-7447.
1994
-
Vaccine-induced neutralizing antibodies directed in part to the simian immunodeficiency virus (SIV) V2 domain were unable to protect rhesus monkeys from SIV experimental challenge..
68:6578-6588.
1994
-
Biological, molecular, and structural analysis of a cytopathic variant from a molecularly cloned simian immunodeficiency virus..
68:5509-5522.
1994
-
Induction in vitro of primary cytotoxic T-lymphocyte responses with DNA encoding herpes simplex virus proteins..
68:5685-5689.
1994
-
Genetic analysis indicates that the human foamy virus Bel-1 protein contains a transcription activation domain of the acidic class..
68:3803-3808.
1994
-
Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes..
68:3410-3414.
1994
-
Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques..
68:2362-2370.
1994
-
Studies of the conformation-dependent neutralizing epitopes of simian immunodeficiency virus envelope protein..
68:2624-2631.
1994
-
T-antigen kinase inhibits simian virus 40 DNA replication by phosphorylation of intact T antigen on serines 120 and 123..
68:269-275.
1994
-
Identification of the activation domain of equine infectious anemia virus rev..
67:7317-7323.
1993
-
Inhibition of Rev activity and human immunodeficiency virus type 1 replication by antisense oligodeoxynucleotide phosphorothioate analogs directed against the Rev-responsive element..
67:6882-6888.
1993
-
Transcriptional trans activators of human and simian foamy viruses contain a small, highly conserved activation domain..
67:6824-6827.
1993
-
Phenotypic and functional consequences of herpesvirus saimiri infection of human CD8+ cytotoxic T lymphocytes..
67:6317-6321.
1993
-
Functional analysis of interactions between Tat and the trans-activation response element of human immunodeficiency virus type 1 in cells..
67:5617-5622.
1993
-
Genetic evidence that the Tat proteins of human immunodeficiency virus types 1 and 2 can multimerize in the eukaryotic cell nucleus..
67:5030-5034.
1993
-
Genetic analysis of the cofactor requirement for human immunodeficiency virus type 1 Tat function..
67:3703-3711.
1993
-
Independent variation and positive selection in env V1 and V2 domains within maternal-infant strains of human immunodeficiency virus type 1 in vivo..
67:3951-3960.
1993
-
Induction of primary, antiviral cytotoxic, and proliferative responses with antigens administered via dendritic cells..
67:4062-4069.
1993
-
La autoantigen enhances and corrects aberrant translation of poliovirus RNA in reticulocyte lysate..
67:3798-3807.
1993
-
Mutational analysis of the leucine zipper-like motif of the human immunodeficiency virus type 1 envelope transmembrane glycoprotein..
67:3615-3619.
1993
-
Complement-mediated binding of naturally glycosylated and glycosylation-modified human immunodeficiency virus type 1 to human CR2 (CD21)..
67:2699-2706.
1993
-
Functional organization of the Bel-1 trans activator of human foamy virus..
67:1896-1904.
1993
-
The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks..
67:1218-1226.
1993
-
Recognition by and in vitro induction of cytotoxic T lymphocytes against predicted epitopes of the immediate-early protein ICP27 of herpes simplex virus..
67:613-616.
1993
-
Plasmid models for bacteriophage T4 DNA replication: requirements for fork proteins..
66:6960-6968.
1992
-
Specific binding of the human T-cell leukemia virus type I Rex protein to a short RNA sequence located within the Rex-response element..
66:7572-7575.
1992
-
Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins..
66:5879-5889.
1992
-
Comparative analysis of Rev function in human immunodeficiency virus types 1 and 2..
66:4288-4294.
1992
-
INVIVO GENETIC-VARIABILITY OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 V3-REGION.
66:4546-4550.
1992
-
In vivo genetic variability of the human immunodeficiency virus type 2 V3 region..
66:4546-4550.
1992
-
The surface envelope protein gene region of equine infectious anemia virus is not an important determinant of tropism in vitro..
66:4085-4097.
1992
-
Cytoplasmic domain truncation enhances fusion activity by the exterior glycoprotein complex of human immunodeficiency virus type 2 in selected cell types..
66:3971-3975.
1992
-
Structural and functional analysis of the visna virus Rev-response element..
66:3609-3615.
1992
-
The Bel-1 protein of human foamy virus activates human immunodeficiency virus type 1 gene expression via a novel DNA target site..
66:3946-3949.
1992
-
Mutational analysis of conserved N-linked glycosylation sites of human immunodeficiency virus type 1 gp41..
66:1799-1803.
1992
-
Unusual structure of the human immunodeficiency virus type 1 trans-activation response element..
66:930-935.
1992
-
Analysis of trans activation by human papillomavirus type 16 E7 and adenovirus 12S E1A suggests a common mechanism..
65:6922-6930.
1991
-
Analysis of trans-acting response decoy RNA-mediated inhibition of human immunodeficiency virus type 1 transactivation..
65:6811-6816.
1991
-
Anti-glycoprotein D monoclonal antibody protects against herpes simplex virus type 1-induced diseases in mice functionally depleted of selected T-cell subsets or asialo GM1+ cells..
65:6008-6014.
1991
-
Role of conserved gp41 cysteine residues in the processing of human immunodeficiency virus envelope precursor and viral infectivity..
65:6349-6352.
1991
-
Lack of enhancing effect of human anti-human immunodeficiency virus type 1 (HIV-1) antibody on HIV-1 infection of human blood monocytes and peritoneal macrophages..
65:4309-4316.
1991
-
Mutational definition of the human immunodeficiency virus type 1 Rev activation domain..
65:4248-4254.
1991
-
Conserved functional organization of the human immunodeficiency virus type 1 and visna virus Rev proteins..
65:3877-3881.
1991
-
Efficient polyadenylation within the human immunodeficiency virus type 1 long terminal repeat requires flanking U3-specific sequences..
65:3340-3343.
1991
-
Characterization of the transcriptional trans activator of human foamy retrovirus..
65:2589-2594.
1991
-
Effects of chimeric mutants of human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex on nucleolar targeting signals..
65:2452-2456.
1991
-
Protein phosphatase 2A dephosphorylates simian virus 40 large T antigen specifically at residues involved in regulation of DNA-binding activity..
65:2098-2101.
1991
-
Human immunodeficiency virus as a prototypic complex retrovirus..
65:1053-1056.
1991
-
Rev activates expression of the human immunodeficiency virus type 1 vif and vpr gene products..
65:1653-1657.
1991
-
Complement-mediated, infection-enhancing antibodies in plasma from vaccinated macaques before and after inoculation with live simian immunodeficiency virus..
64:5223-5225.
1990
-
Kinetics of poliovirus uncoating in HeLa cells in a nonacidic environment..
64:3590-3597.
1990
-
Antibody-dependent enhancement of simian immunodeficiency virus (SIV) infection in vitro by plasma from SIV-infected rhesus macaques..
64:113-119.
1990
-
Association of p62c-yes
with polyomavirus middle T-antigen mutants correlates with transforming ability.
64:1584-1589.
1990
-
Structure and orientation of expressed bovine coronavirus hemagglutinin-esterase protein.
64:1834-1838.
1990
-
Functional analysis of the Tat trans activator of human immunodeficiency virus type 2..
63:5006-5012.
1989
-
Transcription of a poxvirus early gene is regulated both by a short promoter element and by a transcriptional termination signal controlling transcriptional interference..
63:4632-4644.
1989
-
Viral transcription is necessary and sufficient for vesicular stomatitis virus to inhibit maturation of small nuclear ribonucleoproteins..
63:4172-4180.
1989
-
Functional characterization of a complex protein-DNA-binding domain located within the human immunodeficiency virus type 1 long terminal repeat leader region..
63:3213-3219.
1989
-
Mutational analysis of the conserved basic domain of human immunodeficiency virus tat protein..
63:1181-1187.
1989
-
THE 2ND-LARGEST SUBUNIT OF THE POXVIRUS RNA-POLYMERASE IS SIMILAR TO THE CORRESPONDING SUBUNITS OF PROCARYOTIC AND EUKARYOTIC RNA-POLYMERASES.
63:1076-1086.
1989
-
The second-largest subunit of the poxvirus RNA polymerase is similar to the corresponding subunits of procaryotic and eucaryotic RNA polymerases..
63:1076-1086.
1989
-
Cellular gene expression in papillomas of the choroid plexus from transgenic mice that express the simian virus 40 large T antigen..
63:790-797.
1989
-
Identification of a U5-specific sequence required for efficient polyadenylation within the human immunodeficiency virus long terminal repeat..
63:421-424.
1989
-
Phosphorylation of the rev gene product of human immunodeficiency virus type 1..
62:4801-4804.
1988
-
C3b receptor activity on transfected cells expressing glycoprotein C of herpes simplex virus types 1 and 2..
62:4027-4036.
1988
-
Neutralizing antibodies to an immunodominant envelope sequence do not prevent gp120 binding to CD4..
62:4195-4200.
1988
-
Subcellular localization of the human immunodeficiency virus trans-acting art gene product..
62:2498-2501.
1988
-
Simian virus 40 (SV40) T antigen binds specifically to double-stranded DNA but not to single-stranded DNA or DNA/RNA hybrids containing the SV40 regulatory sequences..
62:2204-2208.
1988
-
Mutational analysis of the trans-activation-responsive region of the human immunodeficiency virus type I long terminal repeat..
62:673-679.
1988
-
Fine mapping two distinct antigenic sites on simian virus 40 (SV40) T antigen reactive with SV40-specific cytotoxic T-cell clones by using SV40 deletion mutants..
62:285-296.
1988
-
Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection..
61:2017-2023.
1987
-
Relationship between simian virus 40 large tumor antigen expression and tumor formation in transgenic mice..
61:2029-2032.
1987
-
Nucleic acid sequence and oncogenic properties of the HZ2 feline sarcoma virus v-abl insert..
61:1193-1202.
1987
-
Localization of structural proteins in African swine fever virus particles by immunoelectron microscopy..
58:377-384.
1986
-
Effect of herpes simplex virus types 1 and 2 on surface expression of class I major histocompatibility complex antigens on infected cells..
56:757-766.
1985
-
Selectivity of interferon action in simian virus 40-transformed cells superinfected with simian virus 40..
53:893-898.
1985
-
Transcriptional activity of avian retroviral long terminal repeats directly correlates with enhancer activity..
53:515-521.
1985
-
Fusion of the termini of the murine cytomegalovirus genome after infection..
52:24-28.
1984
-
Sites of copy choice replication involved in generation of vesicular stomatitis virus defective-interfering particle RNAs..
51:515-521.
1984
-
Nucleotide sequence and host La protein interactions of rabies virus leader RNA..
50:773-778.
1984
-
Revertants and partial transformants of rat fibroblasts infected with Fujinami sarcoma virus..
50:325-334.
1984
-
Cytoplasmic localization of the transforming protein of Fujinami sarcoma virus: salt-sensitive association with subcellular components..
45:782-791.
1983
-
RNA polymerase-associated interactions near template promoter sequences of defective interfering particles of vesicular stomatitis virus..
43:241-249.
1982
-
Mutants of Fujinami sarcoma virus which are temperature sensitive for cellular transformation and protein kinase activity..
38:347-355.
1981
-
Simian virus 40 transcriptional complexes incorporate mercurated nucleotides into RNA in vitro..
37:511-517.
1981
-
Site on the vesicular stomatitis virus genome specifying polyadenylation and the end of the L gene mRNA..
34:550-559.
1980
-
Intervening sequence between the leader region and the nucleopcapsid gene of vesicular stomatitis virus RNA..
33:789-794.
1980
-
Terminal sequences of vesicular stomatitis virus RNA are both complementary and conserved..
32:167-174.
1979
-
Topography of a flexible ribonucleoprotein helix: protein-protein contacts in Sendai virus nucleocapsids..
30:701-710.
1979
-
Evidence that a precursor glycoprotein is cleaved to yield the major glycoprotein of avian tumor virus..
21:810-814.
1977
-
Interspecies determinants of Friend leukemia virus antigens involved in cytolysis of virus-pfoducing cells..
21:113-118.
1977
-
Role of carbohydrate in biological functions of Friend murine leukemia virus gp71..
21:35-40.
1977
-
Viral glycoprotein synthesis studies in an established line of Japanese quail embryo cells infected with the Bryan high-titer strain of Rous sarcoma virus..
18:504-510.
1976
-
Purification and serological characterization of the major envelope glycoprotein from AKR murine leukemia virus and its reactivity with autogenous immune sera from mice..
17:727-736.
1976
-
Role of carbohydrate in determining the immunochemical properties of the major glycoprotein (gp71) of Friend murine leukemia virus..
16:1453-1463.
1975
-
Mitosis is required for production of murine leukemia virus and structural proteins during de novo infection..
16:267-274.
1975
-
Expression of the Major Viral Glycoprotein of Avian Tumor Virus in Cells of chf(+) Chicken Embryos..
15:1131-1140.
1975
-
Isolation of two subgroup-specific leukemogenic viruses from standard avian myeloblastosis virus..
15:906-912.
1975
-
Reactivity of avian RNA tumor viruses with lectins..
17:132-139.
1975
-
Outer membrane of avian myeloblastosis virus..
12:1579-1588.
1973
-
Multiple and specific initiation of T4 DNA replication..
12:130-148.
1973
-
In vitro chick embryo cell response to strain MC29 avian leukosis virus..
2:576-586.
1968
-
Correction for Chakrabarti et al., Robust Neutralizing Antibodies Elicited by HIV-1 JRFL Envelope Glycoprotein Trimers in Nonhuman Primates..
89:887.
2015
-
Cross-Reactive HIV-1-Neutralizing Human Monoclonal Antibodies Identified from a Patient with 2F5-Like Antibodies (vol 85, pg 11401, 2011).
87:13936-13936.
2013
-
Erratum to Cross-reactive HIV-1-neutralizing human monoclonal antibodies identified from a patient with 2F5-like antibodies [Journal of Virology, 85, 21, (2011) 11401-11408] DOI: 10.1128/JVI.05312-11.
87:13936.
2013
-
Neutralization-sensitive R5-tropic simian-human immunodeficiency virus SHIV-2873Nip, which carries env isolated from an infant with a recent HIV clade C infection (Journal of Virology (2009) 83, 3, (1422-1432)).
83:8297.
2009
-
Partial protection of simian immunodeficiency virus (SIV)-infected rhesus monkeys against superinfection with a heterologous SIV isolate (Journal of Virology (2009) 83, 6 (2686-2696)).
83:5293.
2009
-
Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines..
79:10103-10107.
2005
-
Erratum: Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles (Journal of Virology (2000) 74:1 (371-378)).
74:3430.
2000
-
Biological, molecular, and structural analysis of a cytopathic variant from a molecularly cloned simian immunodeficiency virus..
68:7665-7667.
1994
-
Priming with a Potent HIV-1 DNA Vaccine Frames the Quality of Immune Responses prior to a Poxvirus and Protein Boost.
2019